Comment on "Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry"

J Am Acad Dermatol. 2021 Sep;85(3):e171. doi: 10.1016/j.jaad.2021.01.102. Epub 2021 Mar 2.

Authors

Hyun-Min Seo¹, Se Uk Oh¹, Se Kwang Park¹, Joung Soo Kim²

Affiliations

¹ Department of Dermatology, Hanyang University Guri Hospital, Korea.
² Department of Dermatology, Hanyang University Guri Hospital, Korea. Electronic address: tuentuen@hanyang.ac.kr.

PMID: 33667539
DOI: 10.1016/j.jaad.2021.01.102

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Dermatitis, Atopic* / drug therapy
Eczema*
Humans
Netherlands
Registries

Substances

Antibodies, Monoclonal, Humanized
dupilumab